Longevity Biomarkers to Track: A Complete Measurement Guide

Most people make their longevity decisions — what to eat, what to take, how hard to train — based on how they feel. Feelings are a poor proxy. You can feel fine while ApoB climbs quietly toward cardiovascular disease. You can feel tired while your VO2 max is excellent. Without data, you cannot tell which interventions are working and which are noise.

Biomarkers give you a measurement-based feedback loop instead of an opinion-based one. The goal is not to optimize every number obsessively — it is to establish a baseline, identify your highest-leverage targets, and track whether your protocol is actually moving the needles that predict healthspan. This guide covers the core panel most longevity-focused adults should track, organized by category, with testing frequency and interpretation notes.

**Cardiovascular risk markers** are the highest-leverage category. Cardiovascular disease remains the leading cause of premature death in developed countries, and most of the risk is detectable and modifiable years before events occur. Request ApoB (apolipoprotein B) rather than or in addition to LDL-C — ApoB counts the actual number of atherogenic particles and is a stronger predictor of cardiovascular events. Target below 80 mg/dL for longevity-focused adults; below 60 mg/dL for high-risk individuals. Test every 6–12 months. Lp(a) is a genetically determined risk factor — test it once, because it does not change meaningfully with lifestyle. Hs-CRP (high-sensitivity C-reactive protein) measures systemic inflammation; below 1.0 mg/L is the target range. Test 1–2 times per year.

**Metabolic markers** identify insulin resistance, blood sugar regulation, and metabolic flexibility — all of which accelerate biological aging when dysregulated. Fasting glucose (target 70–90 mg/dL), fasting insulin (target below 5–7 μIU/mL), and HbA1c (target below 5.4%) together give a fuller picture than any one alone. Triglyceride-to-HDL ratio below 1.5 is a practical insulin resistance proxy. HOMA-IR (calculated from fasting glucose and fasting insulin) provides a composite score; below 1.0 is excellent. Test every 6 months if metabolic health is a concern; annually if results are in range.

**Biological age clocks** are the most direct read on aging rate. Epigenetic clocks — DunedinPACE, GrimAge, PhenoAge — estimate your pace of biological aging from DNA methylation patterns. A DunedinPACE score below 1.0 means aging slower than chronological age; above 1.0 means faster. These tests are available through consumer labs (TruDiagnostic, Elysium, Foxo Bioscience) at $200–$500 per test. Test annually or after a significant protocol change. Note that individual tests have measurement variability — directional trends across 2–3 tests are more meaningful than any single result.

**Kidney and liver function** are essential safety monitors, especially if using any supplements or medications that are metabolized hepatically. eGFR (estimated glomerular filtration rate) above 90 is normal; declining trend matters more than a single number. Creatinine, BUN, and cystatin C give a fuller renal picture. ALT and AST enzymes indicate liver stress; both should be in normal range and not trending up. Test annually as baseline; more frequently if using hepatically processed compounds.

**Thyroid function** affects metabolism, energy, cognition, and body composition profoundly. TSH alone misses many functional issues — request TSH, free T3, and free T4 together. Optimal TSH for longevity is debated but generally 1.0–2.5 mIU/L. Low free T3 is common in aggressive caloric restriction and correlates with reduced metabolic rate. Test annually or if energy or body composition has changed unexpectedly.

**Complete blood count (CBC) and iron markers** identify anemia, chronic inflammation, and iron dysregulation. Ferritin is the key iron storage marker; optimal range for longevity is debated — 50–150 ng/mL for most adults, with very high ferritin (above 300) associated with increased oxidative stress. Test annually.

**VO2 max** is arguably the single strongest predictor of all-cause mortality across dozens of large studies. A 1-MET increase in cardiorespiratory fitness reduces mortality risk by approximately 13%. You do not need a metabolic cart to estimate it — most modern wearables (Garmin, Polar, Apple Watch) provide reasonable estimates from heart rate during vigorous activity. For a more accurate measurement, structured exercise tests are available through sports medicine labs and some longevity clinics. Target: top quartile for your age and sex. Elite for longevity purposes (Peter Attia's framing): 50+ mL/kg/min for men, 45+ for women at any age. See /blog/vo2-max-and-mortality-risk for evidence depth.

**Grip strength** is a surprisingly powerful functional biomarker. Multiple large cohort studies show that grip strength at midlife predicts cognitive decline, cardiovascular events, fall risk, and all-cause mortality decades later. It is easy to measure with a hand dynamometer ($30–$50). Age-specific reference values are available; for men 40–49 the average is approximately 46–48 kg. Test quarterly alongside your training.

**Gait speed** — simply how fast you walk across a short distance (typically 4 meters) — predicts mortality, hospitalization, and functional decline in older adults with remarkable precision. Below 0.8 m/s is considered high risk. Above 1.2 m/s is associated with substantially lower mortality. As a practical proxy, brisk walking speed during your normal errands is a useful informal tracker.

**Muscle mass and body composition** are typically measured via DEXA scan — the most accessible and accurate method for most people. Appendicular lean mass index (ALMI) — lean mass of arms and legs divided by height squared — is the clinical standard for sarcopenia screening. Men below 7.0 kg/m² and women below 5.5 kg/m² are below the sarcopenia threshold. Target: above the 75th percentile for your age group. DEXA also measures visceral adipose tissue (VAT), which is more metabolically harmful than total body fat. Test every 12–24 months.

Epigenetic clocks have emerged as the most direct available window into aging rate. They work by measuring DNA methylation patterns at specific sites across the genome — aging leaves a predictable signature that can be read from a blood sample. Different clocks are optimized for different outcomes. GrimAge was trained to predict mortality and disease — it is one of the best predictors of healthspan outcomes in published research. PhenoAge predicts a composite of aging-related phenotypes. DunedinPACE is unique: rather than estimating biological age, it estimates your current pace of aging (1.0 = aging at chronological rate; 0.8 = 20% slower; 1.2 = 20% faster). See /blog/biological-age-testing-guide for a full comparison of available tests, labs, and what to do with results.

Important caveats: individual clock results have measurement noise. A single test result should be treated as a rough estimate, not a precise number. Changes of 1–2 years between tests may not be meaningful — trends across multiple tests over time are the signal worth tracking. Clocks are also sensitive to acute stressors (illness, poor sleep in the weeks before testing, significant caloric restriction) which can temporarily elevate readings. Test under stable, representative conditions.

Modern wearables have moved from step counters to serious physiological monitors. The most useful continuous metrics for longevity purposes are: Resting heart rate (RHR) — a declining trend over months reflects improving cardiovascular fitness. Heart rate variability (HRV) — reflects autonomic nervous system balance and recovery quality. HRV is noisy day-to-day but trends over weeks are meaningful. Respiratory rate — often the first objective signal of illness before symptoms appear. Sleep staging and sleep duration — see /blog/sleep-regularity-longevity-circadian-consistency for the evidence on sleep regularity and lifespan. Blood oxygen saturation (SpO2) during sleep — can flag undiagnosed sleep apnea, which dramatically accelerates biological aging if untreated.

For a detailed breakdown of Oura Ring, WHOOP, and Apple Watch for longevity tracking purposes — including how each device handles HRV, sleep staging, and readiness scoring — see /blog/best-wearable-for-longevity-2026-oura-whoop-apple-watch.

Most people should not try to track everything at once. Start with the highest-leverage markers that give you the most information per dollar and per blood draw. A practical Tier 1 panel for longevity-focused adults who are otherwise healthy: ApoB, Lp(a) (once), fasting glucose, fasting insulin, HbA1c, TSH + free T3, CBC with differential, ferritin, ALT, AST, eGFR, vitamin D (25-OH), hs-CRP, and magnesium (RBC magnesium is more accurate than serum). This panel costs $200–$400 out-of-pocket with direct-to-consumer labs (Function Health, LabCorp, Quest, Marek Health, Ulta Lab Tests) and covers the most impactful risk areas.

Add to this panel over time based on your results and risk profile: testosterone (free and total) for men over 40, DHEA-S, homocysteine (elevated with MTHFR variants — raises cardiovascular and cognitive risk), IGF-1, and cortisol if adrenal function is a concern. Epigenetic clocks annually if you can afford it — or once to establish a baseline and again after a 12–18 month protocol.

Frequency recommendation: core blood panel every 6 months if actively optimizing, annually for maintenance. VO2 max estimated quarterly via wearable, confirmed via structured test every 12–18 months. Grip strength quarterly. DEXA annually or every 2 years. Epigenetic clock annually.

A biomarker result only matters if you know what to do with it. The most common mistake is chasing numbers without a protocol logic. Before testing, define your targets and your decision rules: if ApoB is above X, I will do Y. If HbA1c is above X, I will do Z. Pre-committing to interpretation prevents you from rationalizing away unfavorable results.

The second mistake is single-point thinking. One result tells you where you are today. Two results tell you direction. Three results tell you whether the intervention is working. Do not make major changes after a single test unless the result is severely out of range. Establish a baseline, implement one or two protocol changes, and retest after 12 weeks.

The third mistake is over-responding to normal variation. Biomarkers fluctuate. hs-CRP can double with a minor infection or after a hard training block. HRV varies by 20–30% week to week based on sleep, stress, and alcohol. ApoB can shift by 5–10% between draws without any meaningful change. Focus on trends rather than single numbers.

Use your biomarker data to prioritize interventions. If ApoB is elevated, that is a higher-leverage target than optimizing your already-normal HbA1c. If VO2 max is in the bottom quartile for your age, cardiovascular training is a higher-leverage investment than adding another supplement. Data reveals where the actual gaps are — which is rarely where the marketing energy is pointing.

Here is the full recommended tracking stack at a glance: **Blood — Tier 1 (every 6 months):** ApoB, hs-CRP, fasting glucose, fasting insulin, HbA1c, TSH + free T3, CBC, ferritin, ALT, AST, eGFR, 25-OH vitamin D, magnesium (RBC). **Blood — Tier 2 (annually or once):** Lp(a) once, testosterone (men 40+), homocysteine, DHEA-S, IGF-1. **Performance (quarterly):** VO2 max estimate via wearable, grip strength, gait speed assessment. **Body composition (annually):** DEXA for ALMI and visceral fat. **Biological age (annually):** Epigenetic clock (DunedinPACE or GrimAge). **Continuous (wearable):** RHR trend, HRV trend, sleep duration and regularity, SpO2.

This measurement stack is linked to the rest of the site's evidence-based content. For blood test interpretation: /blog/blood-tests-for-longevity. For biological age testing options: /blog/biological-age-testing-guide. For wearable selection: /blog/best-wearable-for-longevity-2026-oura-whoop-apple-watch. For VO2 max training: /blog/vo2-max-and-mortality-risk. For ApoB and cardiovascular risk: /blog/apob-lowering-longevity-guide. For insulin resistance: /blog/insulin-resistance-longevity-reset. Take the healthspan quiz at /quiz/healthspan to get a personalized tracking priority list based on your current protocol.

**What is the most important longevity biomarker?** If you can only measure one thing, measure VO2 max. It is the strongest single predictor of all-cause mortality across the largest and longest-running studies. The second most important are ApoB and fasting insulin — together they identify the two biggest risk categories (cardiovascular disease and metabolic disease) while they are still modifiable.

**Do I need to go to a doctor to get longevity biomarkers tested?** Not necessarily. In most US states, direct-to-consumer labs (Function Health, Marek Health, Ulta Lab Tests, LabCorp Patient) allow you to order your own blood panels without a physician order. Pricing varies widely — the same tests can cost 5–10x more depending on the lab. Epigenetic clock tests are all direct-to-consumer. For prescription medications and some specialty tests, you will need a clinician.

**How much does a full longevity biomarker panel cost?** The Tier 1 blood panel runs $150–$350 via direct-to-consumer labs depending on what you include and the lab you use. DEXA scans are $50–$150 depending on location. Epigenetic clock tests are $200–$500. VO2 max testing via a formal lab test is $100–$300. For most people, the full annual stack runs $500–$1,000 self-pay. This is usually cheaper than most supplement stacks and provides far more decision-relevant information.

**How do I know if my protocol is working?** Define your targets before you start, test at baseline, implement changes for 12 weeks, then retest. Look for directional improvement in 2–3 markers in your highest-leverage category. Do not expect every marker to improve simultaneously — identify your biggest gaps and address those first. If ApoB drops and hs-CRP drops after adding a Zone 2 training block, that is evidence the protocol worked.

**Which wearable is best for tracking longevity biomarkers?** Oura Ring 4 currently leads for sleep tracking accuracy and HRV reliability. WHOOP 5.0 leads for training load and recovery scoring for athletes. Apple Watch Ultra leads for GPS-based cardio training and VO2 max estimation. For longevity monitoring focused on sleep + HRV + readiness, Oura is typically the recommendation. Full comparison at /blog/best-wearable-for-longevity-2026-oura-whoop-apple-watch.

**Are epigenetic clocks accurate enough to act on?** They are accurate enough to establish a directional baseline and track major trends. They are not accurate enough to make decisions based on 1–2 year differences between tests. Use them as a broad signal — if your DunedinPACE is consistently above 1.0 across multiple tests, that is meaningful. If it moves from 1.15 to 0.95 after 18 months of protocol change, that is evidence worth noting. Do not change your entire protocol based on a single result. **Disclaimer:** This content is educational and does not constitute medical advice. Biomarker interpretation should be reviewed with a qualified clinician, especially for results that are significantly outside reference ranges. AliveLongevity content reflects published research as of March 2026.